Weekly News Recap #Phispers
FDA rejects first MDMA therapy to treat PTSD; Merck, Curon ink up to US$ 1.3 bn deal for next-gen bispecific antibody
The US Food and Drug Administration (FDA) has declined to approve an MDMA-assisted therapy from Lykos Therapeutics to treat pos...
Impressions : 1812
Kodak, Fujifilm get millions from US government to produce drugs; Trump’s orders to check drug prices upsets industry
This week, Phispers brings you news on four executive orders issued by the Trump administration to keep drug prices under check...
Impressions : 73174
FDA chief Gottlieb resigns; BMS-Celgene deal may get derailed due to shareholder opposition
This week, Phispers brings you news about the sudden and unexpected resignation of the USFDA commissioner Scott Gottlieb, a day...
Impressions : 3392
Expose on medical device failures and outrage over birth of genetically-edited babies in China grips pharma world
This
week, Phispers tells you how an exposé by the International Consortium of Investigative Journalists
(ICIJ) on med...
Impressions : 2018
New Twists to Sartans Impurities Saga; Fish Oil Drug Makes Heart Medicine History
This week, Phispers brings you new twists to the valsartan impurities saga.
First, the FDA posted its observations at Zhejiang...
Impressions : 3644
Sun, Dr. Reddy’s rework strategies to deal with US market; Novartis sells troubled US biz to Aurobindo
This week, Phispers has news on Indian generic drug makers. First, Sun Pharma and Dr. Reddy’s Laboratories announced thei...
Impressions : 2939
FDA, EMA highlight more concerns over APIs from China; FDA slams Apotex’s India operations
This week, Phispers brings you more news on quality problems with active pharmaceutical ingredients from China. The FDA commiss...
Impressions : 4966
Advent may acquire Sanofi’s European generic unit; Shire sells cancer unit to Servier
This week, Phispers brings you lots of news from the world of M&As. While Advent has reportedly shown interest in acquiring...
Impressions : 2217

